| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chemomab Therapeutics Ltd. (CMMB) has 1 insider with recent SEC Form 4 filings, including 11 buys and 0 sells. CMMB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 134.2K | $205.5K | +9.8K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Marvin Donald | Executive VP, CFO &COO | Buy | 1,250 | $4.04 | $5,045.00 | +38.5% | -15.4% | -62.5% | |
| Mar 14, 2022 | Pfost Dale R | Chief Executive Officer | Buy | 2,500 | $3.98 | $9,943.00 | +138.9% | -15.4% | -62.5% | |
| Mar 11, 2022 | Darvish Nissim | Director | Buy | 1,200 | $4.28 | $5,136.00 | New | -7.9% | -64.8% | |
| Dec 6, 2021 | Cohen Neil Harris | Director | Buy | 2,000 | $7.43 | $14,860.00 | +83.0% | -52.5% | -73.6% | |
| Mar 16, 2021 | Cohen Neil Harris | Director | Buy | 2,409 | $41.51 | $99,997.59 | New | -70.7% | -94.4% | |
| Mar 16, 2021 | Thiel Peter | 10% Owner | Buy | 230,536 | $0.00 | - | +26.3% | -70.7% | -94.4% |